Bayer's blood-clot drug beats Lovenox in key study
642763
Bayer AG's  experimental pill rivaroxaban is significantly more effective than standard injections of Lovenox in preventing blood clots after knee surgery, researchers said on Sunday.
44900
A new study has found that Aleve, a popular over-the-counter painkiller made by Bayer, could increase heart problems.
97553
A widely publicized study that has already linked hormone replacement therapy to an increased risk of stroke, heart attack and some cancers also uncovered a blood clot hazard, researchers reported on Tuesday.
453137
An experimental drug from Eli Lilly reduced heart attacks in patients with heart disease by 24 percent compared with the current standard treatment.
304307
Pfizer Inc. on Friday said two small  clinical trials showed heart bypass surgery patients taking  Bextra, an anti-inflammatory in the same class as the recently  withdrawn drug Vioxx, had a higher risk of stroke and heart  attack.
296681
Two small clinical trials showed heart bypass surgery patients taking Bextra, an anti-inflammatory in the same class as the recently withdrawn drug Vioxx, had an increased risk of stroke and heart attack.
107681
An experimental thrombosis pill from   Bayer AG, seen by analysts as the German group's most important   pipeline asset, has produced promising results in two clinical   trials, researchers said on Tuesday.
729940
NEW YORK, OCTOBER 15 : PFIZER Inc. on Friday said two clinical trials showed patients taking its anti-inflammatory drug Bextra, had a higher risk of cardio-vascular events during high-risk coronary bypass surgery.
196823
A potent new anti-clotting drug from Eli  Lilly and Co proved as safe and effective as Sanofi-Aventis's  top-seller Plavix in a mid-stage clinical trial, researchers  said on Sunday.  Now Lilly and its partner Sankyo Co. Ltd. aim to demonstrate  clear superiority for their compound, known as prasugrel or  CS-747, in a much larger Phase III study involving up to 13,000  patients that is about to get under way.
32938
A drug being developed by Bayer AG and Onyx Pharmaceuticals shrank tumors in 9 percent of liver cancer patients in a mid-stage clinical trial, the companies said on Wednesday.
435430
Schering-Plough Corporation has announced that it has entered into a strategic agreement with Bayer designed to maximize the companies&#39; pharmaceutical resources while maintaining each company&#39;s own strategic interests.
453467
Shorter courses of chemotherapy taken  with Roche Holding AG's cancer drug MabThera are as effective  as longer courses in elderly patients with aggressive lymphoma,  a study in The Lancet Oncology showed.
704534
Bayer HealthCare, a U.S.-based unit of Bayer AG  , stopped a late-stage trial of Nexavar in patients  with non-small cell lung cancer, after an independent data  monitoring committee concluded that the study would not meet  the main goal of improved overall survival.
227799
Drugmakers Merck & Co.  and Schering-Plough Corp.  reported second-quarter results that handily topped Wall Street expectations on Monday, helped by increased sales of the cholesterol-lowering drugs they co-market and other medicines.
653662
A long-acting form of Bayer's blood  pressure drug Adalat prevents heart attacks and strokes in  angina patients and cuts the need for operations to treat blood  vessel blockages, a study showed on Sunday.
24676
Bayer AG forged an alliance for its struggling pharmaceuticals business with US drugmaker Schering-Plough on Monday, cutting costs and marking another step in the German company&#39;s transformation.
671957
Shares in the German chemicals and pharmaceuticals giant Bayer were higher on the stock exchange after the maker of Aspirin painkiller said it was axeing 1,500 jobs in its underperforming agrochemicals division.